The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

Osteoporosis International

Volumn 21, Issue 1, 2010, Pages 41-52

  Dawson Hughes, B ^a   Looker, A C ^b   Tosteson, A N A ^c   Johansson, H ^d   Kanis, J A ^d   Melton III, L J ^e  

^a TUFTS UNIVERSITY   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e MAYO CLINIC   (United States)

Author keywords

National Osteoporosis Foundation Clinician's Guide; Osteoporosis; Osteoporosis risk factors; Prevalence; Treatment eligibility population based study

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NON PROFIT ORGANIZATION; NUTRITION; OSTEOPOROSIS; POSTMENOPAUSE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; WORLD HEALTH ORGANIZATION;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 75249084513     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1034-7     Document Type: Article

References (33)

1. SH Gehlbach JS Avrunin E Puleo 2007 Trends in hospital care for hip fractures Osteoporos Int 18 585 591 10.1007/s00198-006-0281-0 1:STN:280:DC%2BD2s7ptFGquw%3D%3D 17146592 (Pubitemid 46525536)
2. LJ Melton 3rd AE Kearns EJ Atkinson ME Bolander SJ Achenbach JM Huddleston TM Therneau CL Leibson 2009 Secular trends in hip fracture incidence and recurrence Osteoporos Int 20 687 694 10.1007/s00198-008-0742-8 18797813
3. R Burge B Dawson-Hughes DH Solomon JB Wong A King A Tosteson 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465 475 10.1359/jbmr.061113 17144789 (Pubitemid 46797130)
4. National Osteoporosis Foundation (2008) Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, D C, pp 1-36
5. Kanis J (2008) Assessment of osteoporosis at the primary health-care level. WHO Collaborating Centre, University of Sheffield, Sheffield, UK In Group WHOS
6. AN Tosteson LJ Melton 3rd B Dawson-Hughes S Baim MJ Favus S Khosla RL Lindsay 2008 Cost-effective osteoporosis treatment thresholds: the United States perspective Osteoporos Int 19 437 447 10.1007/s00198-007-0550-6 1:STN:280:DC%2BD1c7nvF2ntg%3D%3D 18292976
7. National Osteoporosis Foundation (2005) Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
8. DM Eddy CC Johnston Jr SR Cummings 1998 Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis Osteoporos Int 8 S1 S88 10.1007/s001980050040 (Pubitemid 28085477)
9. Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. In Services DoHaH (ed). Center for Disease Control and Prevention, Atlanta, GA
10. (1977) Standards and guidelines for federal statistics: race and ethnic standards for federal statistics and administrative reporting. In Budget OoMa (ed). Federal Register.
11. HW Wahner A Looker WL Dunn LC Walters MF Hauser C Novak 1994 Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers J Bone Miner Res 9 951 960 1:STN:280: DyaK2czmtVOqtg%3D%3D 8079669
12. AC Looker HW Wahner WL Dunn MS Calvo TB Harris SP Heyse CC Johnston Jr R Lindsay 1998 Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 468 489 10.1007/s001980050093 1:STN:280:DyaK1M%2FmslensA%3D%3D 9850356 (Pubitemid 28486716)
13. SM McKinlay 1994 Issues in design, measurement, and analysis for menopause research Exp Gerontol 29 479 493 10.1016/0531-5565(94)90029-9 1:STN:280:DyaK2M%2FhtVCktw%3D%3D 7925766
14. Denniston PL, Epner JA (1993) 1993 physicians' GenRx. Data Pharmaceutica, New York
15. MA Hansen K Overgaard BJ Riis C Christiansen 1991 Potential risk factors for development of postmenopausal osteoporosis-examined over a 12-year period Osteoporos Int 1 95 102 10.1007/BF01880450 1:STN:280:DyaK387mtlKmsg%3D%3D 1790399
16. EK Rasch R Hirsch R Paulose-Ram MC Hochberg 2003 Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification Arthritis Rheum 48 917 926 10.1002/art.10897 12687533 (Pubitemid 36418233)
17. CG Helmick DT Felson RC Lawrence S Gabriel R Hirsch CK Kwoh MH Liang HM Kremers MD Mayes PA Merkel SR Pillemer JD Reveille JH Stone 2008 Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum 58 15 25 10.1002/art.23177 18163481
18. JA Kanis A Oden O Johnell H Johansson C De Laet J Brown P Burckhardt C Cooper C Christiansen S Cummings JA Eisman S Fujiwara C Gluer D Goltzman D Hans MA Krieg A La Croix E McCloskey D Mellstrom LJ Melton 3rd H Pols J Reeve K Sanders AM Schott A Silman D Torgerson T van Staa NB Watts N Yoshimura 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033 1046 10.1007/s00198-007-0343-y 1:STN:280:DC%2BD2sznvV2hug%3D%3D 17323110 (Pubitemid 47020000)
19. R. Osteoporos Int doi: 10.1007/s00198-009-1032-9
20. VM Montori GH Guyatt 2001 What is evidence-based medicine and why should it be practiced? Respir Care 46 1201 1214 1:STN:280:DC%2BD3Mrnt1ajtA%3D%3D 11679142
21. AM O'Connor JE Wennberg F Legare HA Llewellyn-Thomas BW Moulton KR Sepucha AG Sodano JS King 2007 Toward the 'tipping point': decision aids and informed patient choice Health Aff (Millwood) 26 716 725 10.1377/hlthaff.26.3. 716
22. JR Curtis L Carbone H Cheng B Hayes A Laster R Matthews KG Saag R Sepanski SB Tanner E Delzell 2008 Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005 J Bone Miner Res 23 1061 1067 10.1359/jbmr.080232 18302495 (Pubitemid 351915728)
23. RS Vasan A Beiser S Seshadri MG Larson WB Kannel RB D'Agostino D Levy 2002 Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham heart study JAMA 287 1003 1010 10.1001/jama.287.8.1003 11866648 (Pubitemid 34252058)
24. MG Donaldson PM Cawthon LY Lui JT Schousboe KE Ensrud BC Taylor JA Cauley TA Hillier DM Black DC Bauer SR Cummings 2009 Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. national osteoporosis foundation guidelines J Bone Miner Res 24 675 680 10.1359/jbmr.081203 19049330
25. B Dawson-Hughes SS Harris GE Dallal DR Lancaster Q Zhou 2002 Calcium supplement and bone medication use in a US medicare health maintenance organization Osteoporos Int 13 657 662 10.1007/s001980200089 1:CAS:528:DC%2BD38Xns1entb8%3D 12181625 (Pubitemid 34885858)
26. E Lee AK Wutoh Z Xue JJ Hillman IH Zuckerman 2006 Osteoporosis management in a Medicaid population after the Women's Health Initiative study J Womens Health (Larchmt) 15 155 161 10.1089/jwh.2006.15.155
27. AN Tosteson MR Grove CS Hammond MM Moncur GT Ray GM Hebert AR Pressman B Ettinger 2003 Early discontinuation of treatment for osteoporosis Am J Med 115 209 216 10.1016/S0002-9343(03)00362-0 12947959 (Pubitemid 37338146)
28. DH Solomon J Avorn JN Katz JS Finkelstein M Arnold JM Polinski MA Brookhart 2005 Compliance with osteoporosis medications Arch Intern Med 165 2414 2419 10.1001/archinte.165.20.2414 16287772 (Pubitemid 41640855)
29. AC Feldstein J Schneider DH Smith WM Vollmer M Rix H Glauber DL Boardman M Herson 2008 Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture Osteoporos Int 19 1527 1540 10.1007/s00198-008- 0605-3 1:STN:280:DC%2BD1cnksVeksw%3D%3D 18373049
30. GM Kiebzak GA Beinart K Perser CG Ambrose SJ Siff MH Heggeness 2002 Undertreatment of osteoporosis in men with hip fracture Arch Int Med 162 2217 2222 10.1001/archinte.162.19.2217 (Pubitemid 35231591)
31. SM Cadarette JN Katz MA Brookhart R Levin MR Stedman NK Choudhry DH Solomon 2008 Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004 J Rheumatol 35 319 326 18061977
32. AA Hedley CL Ogden CL Johnson MD Carroll LR Curtin KM Flegal 2004 Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002 JAMA 291 2847 2850 10.1001/jama.291.23.2847 1:CAS:528: DC%2BD2cXkvFKnsbw%3D 15199035 (Pubitemid 38747805)
33. AC Looker CM Pfeiffer DA Lacher, et al. 2008 Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004 Am J Clin Nutr 88 1519 1527 10.3945/ajcn.2008.26182 1:CAS:528:DC%2BD1MXhvVygtLo%3D 19064511